Isolation and Detection of Exosomal Mir210 Using Carbon Nanomaterial-Coated Magnetic Beads
Source abstract
Abstract
MicroRNAs (miRNAs) are short non-coding RNAs that are found in various cellular compartments and play an important role in regulating gene expression. Extracellular miRNAs, such as those found within extracellular vesicles such as exosomes are involved in cell-to-cell communication. The intercellular transfer of miRNAs has been implicated in various diseases’ pathogenesis including cancer and has been studied extensively as potential cancer biomarkers. However, the extraction of miRNA from exosomes is still a challenging task. The current nucleic acid extraction assays are expensive and labor-intensive. In this study, we demonstrated a microfluidic device for aptamer-based magnetic separation of the exosomes and subsequent detection of the miRNA using a fluorescence switching assay, which was enabled by carbon nanomaterials coated on magnetic beads. In the OFF state, the fluorophore-labelled cDNA is quenched using carbon nanomaterials. However, when the target miRNA210 is introduced, the cDNA detaches from the bead’s surface, which leads to an increase in the fluorescence intensity (ON state). This increment was found to be proportional to miRNA concentration within the dynamic range of 0–100 nM with a detection limit of 5 pM. The assay was validated with spiked miRNA using the standard RT-PCR method. No notable cross-reactivity with other closely related miRNAs was observed. The developed method can be utilized for the minimally invasive detection of cancer biomarkers.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Advanced biosensing and bioanalysis techniques · Nanowire Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Alfaisal University, Al Zahrawi Street, Al Maather, Al Takhassusi Rd, Riyadh 11533, Saudi Arabia
References (37)
Show source-provided references
1. Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2021, February 11). Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer. Available online: https://gco.iarc.fr/today.
2. Cancer diagnosis: From tumor to liquid biopsy and beyond
3. Exosomal noncoding RNAs in Glioma: Biological functions and potential clinical applications10.1186/s12943-020-01189-3 ↗
4. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities10.1002/jcp.26481 ↗
5. Exosomes: Biogenesis, biologic function and clinical potential10.1186/s13578-019-0282-2 ↗
6. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models10.1016/j.addr.2012.08.007 ↗
7. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review10.1002/ijc.32688 ↗
8. Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements10.1007/s00018-012-0990-9 ↗
9. Bottani, M., Banfi, G., and Lombardi, G. (2019). Circulating miRNAs as diagnostic and prognostic biomarkers in common solid tumors: Focus on lung, breast, prostate cancers, and osteosarcoma. J. Clin. Med., 8.10.3390/jcm8101661 ↗
10. Cell-to-cell communication: MicroRNAs as hormones10.1002/1878-0261.12144 ↗
11. Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis10.1111/j.1349-7006.2010.01650.x ↗
12. The microRNA spectrum in 12 body fluids10.1373/clinchem.2010.147405 ↗
13. MicroRNAs in body fluids—The mix of hormones and biomarkers10.1038/nrclinonc.2011.76 ↗
14. Cell-free microRNAs as cancer biomarkers: The odyssey of miRNAs through body fluids10.1007/s12032-014-0295-y ↗
15. Review on strategies and technologies for exosome isolation and purification10.3389/fbioe.2021.811971 ↗
16. Sidhom, K., Obi, P.O., and Saleem, A. (2020). A review of exosomal isolation methods: Is size exclusion chromatography the best option?. Int. J. Mol. Sci., 21.10.20944/preprints202007.0485.v2 ↗
17. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications10.1038/s41598-019-41800-2 ↗
18. Song, Z., Mao, J., Barrero, R.A., Wang, P., Zhang, F., and Wang, T. (2020). Development of a CD63 aptamer for efficient cancer immunochemistry and immunoaffinity-based exosome isolation. Molecules, 25.10.3390/molecules25235585 ↗
19. Alomran, N., Chinnappan, R., Alsolaiss, J., Casewell, N.R., and Zourob, M. (2022). Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming. Toxins, 14.10.1101/2022.05.22.492967 ↗
20. Gas phase synthesis of fcc-cobalt nanoparticles10.1039/b601013j ↗
21. Preferential magnetic targeting of carbon nanotubes to cancer sites: Noninvasive tracking using MRI in a murine breast cancer model10.2217/nnm.14.145 ↗
22. Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles’ characteristics compared to precipitating agents10.1038/srep33641 ↗
23. Flow-through immunomagnetic separation system for waterborne pathogen isolation and detection: Application to Giardia and Cryptosporidium cell isolation10.1016/j.aca.2010.05.025 ↗
24. Chugh, P.E., Sin, S.H., Ozgur, S., Henry, D.H., Menezes, P., Griffith, J., Eron, J.J., Damania, B., and Dittmer, D.P. (2013). Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog., 9.10.1371/journal.ppat.1003484 ↗
25. Fornari, F., Ferracin, M., Trerè, D., Milazzo, M., Marinelli, S., Galassi, M., Venerandi, L., Pollutri, D., Patrizi, C., and Borghi, A. (2015). Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, identify cirrhotic patients with HCC. PLoS ONE, 10.10.1371/journal.pone.0141448 ↗
26. Köberle, V., Pleli, T., Schmithals, C., Augusto Alonso, E., Haupenthal, J., Bönig, H., Peveling-Oberhag, J., Biondi, R.M., and Zeuzem Kronenberger, S.B. (2013). Differential stability of cell-free circulating microRNAs: Implications for their utilization as biomarkers. PLoS ONE, 8.10.1371/journal.pone.0075184 ↗
27. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance10.3324/haematol.2013.093500 ↗
28. Rapid Capture and Nondestructive Release of Extracellular Vesicles Using Aptamer-Based Magnetic Isolation10.1021/acssensors.9b00060 ↗
29. Dynamic light scattering for the characterization and counting of extracellular vesicles: A powerful noninvasive tool10.1007/s11051-014-2583-z ↗
30. Nucleic acid detection using carbon nanoparticles as a fluorescent sensing platform10.1039/C0CC04326E ↗
31. Aptameric biosensor for the sensitive detection of major shrimp allergen, tropomyosin10.1016/j.foodchem.2019.126133 ↗
32. Probing high-affinity aptamer binding region and development of aptasensor platform for the detection of cylindrospermopsin10.1007/s00216-020-02723-4 ↗
33. A signal-on fluorescence-based strategy for detection of microRNA-21 based on graphene oxide and λ exonuclease-based signal amplification10.1039/D1AY00309G ↗
34. A simple G-quadruplex molecular beacon-based biosensor for highly selective detection of microRNA10.1016/j.bios.2016.07.060 ↗
35. Label-free microRNA detection based on fluorescence quenching of gold nanoparticles with a competitive hybridization10.1021/acs.analchem.5b01930 ↗
36. Amplified fluorescence sensing of miRNA by combination of graphene oxide with duplex-specific nuclease10.1039/C4AY00345D ↗
37. Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., and Zhang, G. (2017). Chemical modifications of nucleic acid aptamers for therapeutic purposes. Int. J. Mol. Sci., 18.10.3390/ijms18081683 ↗